self-assembling influenza nanoparticle vaccines elicit broadly neutralizing h1n1 antibodies 
influenza viruses pose significant threat public burden global health systems year influenza vaccines must rapidly produced match circulating viruses process constrained dated technology vulnerable unexpected strains emerging humans animal reservoirs use knowledge protein structure design self-assembling nanoparticles elicit broader potent immunity traditional influenza vaccines viral haemagglutinin genetically fused ferritin protein naturally forms nanoparticles composed identical polypeptides haemagglutinin inserted interface adjacent subunits spontaneously assembled generated eight trimeric viral spikes surface immunization influenza nanoparticle vaccine elicited haemagglutination inhibition antibody titres tenfold higher licensed inactivated vaccine furthermore elicited neutralizing antibodies two highly conserved vulnerable haemagglutinin structures targets universal vaccines: stem receptor binding site head antibodies elicited haemagglutinin-nanoparticle vaccine neutralized h1n1 viruses protected ferrets unmatched h1n1 virus challenge structure-based self-assembling synthetic nanoparticle vaccine improves potency breadth influenza virus immunity provides foundation building broader vaccine protection emerging influenza viruses pathogens 
